EFFICACY AND SAFETY OF USTEKINUMAB INTRAVENOUS INDUCTION IN A COHORT OF PATIENTS WITH CROHN´S DISEASE REFRACTORY TO ANTI-TUMOR NECROSIS FACTOR AGENTS
Aurélia Santoni 1
Mélanie Serrero 1
Romain Altwegg 2
Ariadne Desjeux 1
Lucile Boivineau 2
Jean-Charles Grimaud 1
1 Hopital Nord,Marseille,France
2 Hôpital Saint Eloi, CHRU Montpellier,Montpellier,France
Conference
UEG Week 2018
Citation
United European Gastroenterology Journal 2018; 6 (Supplement 1)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]
Social Sharing